Large-scale testing (Phase 3)Study completedNCT01202903
What this trial is testing
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
Who this might be right for
Persistent Allergic Asthma
Novartis Pharmaceuticals 616